Abstract
Background
Respiratory failure in patients with Guillain-Barré syndrome (GBS) can lead to serious complications and dysfunctions, emphasizing the importance of early detection. The C-reactive protein-to-albumin ratio (CAR) is emerging as a novel inflammatory marker for predicting neurological outcome. We aimed to identify the association of CAR with respiratory failure and short-term outcome in GBS patients.
Methods
A total of 200 patients diagnosed with GBS were retrospectively analyzed. Data were collected from an electronic database. The associations of C-reactive protein (CRP), albumin, and CAR at admission with outcomes were evaluated by logistic regression analysis. Using receiver operating characteristic curves, we calculated the cutoff value for the CAR and compared its discriminatory power with that of C-reactive protein alone.
Results
Fifty-two (26%) patients showed poor short-term outcome, and 50 (25%) developed respiratory failure. CAR > 0.21 was an independent predictor of respiratory failure, and CAR > 0.19 was an independent predictor of poor short-term outcome. CAR showed a better predictive value than CRP alone. In addition, the c-index of the predictive nomogram for respiratory failure was higher when it included CAR (0.962) than when it did not (0.958). A similar result was observed for the predictive nomogram for poor short-term outcome (0.953 vs 0.947).
Conclusion
CAR > 0.21, a novel inflammatory biomarker, is independently associated with the occurrence of respiratory failure in GBS patients, while CAR > 0.19 is independently associated with poor short-term outcome. CAR may help identify GBS patients at high risk of poor prognosis.
Similar content being viewed by others
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
van Koningsveld R, Steyerberg EW, Hughes RA, Swan AV, van Doorn PA, Jacobs BC (2007) A clinical prognostic scoring system for Guillain-Barre syndrome. Lancet Neurol 6(7):589–594
McGrogan A, Madle GC, Seaman HE, de Vries CS (2009) The epidemiology of Guillain-Barre syndrome worldwide. A systematic literature review. Neuroepidemiology. 32(2):150–163
Dhar R, Stitt L, Hahn AF (2008) The morbidity and outcome of patients with Guillain-Barre syndrome admitted to the intensive care unit. J Neurol Sci 264(1–2):121–128
Fletcher DD, Lawn ND, Wolter TD, Wijdicks EF (2000) Long-term outcome in patients with Guillain-Barre syndrome requiring mechanical ventilation. Neurology. 54(12):2311–2315
Rees JH, Thompson RD, Smeeton NC, Hughes RA (1998) Epidemiological study of Guillain-Barre syndrome in south east England. J Neurol Neurosurg Psychiatry 64(1):74–77
Winer JB, Hughes RA, Osmond C (1988) A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry 51(5):605–612
McMillan DC (2009) Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12(3):223–226
Kaplan M, Ates I, Akpinar MY, Yuksel M, Kuzu UB, Kacar S, Coskun O, Kayacetin E (2017) Predictive value of C-reactive protein/albumin ratio in acute pancreatitis. Hepatobiliary Pancreat Dis Int 16(4):424–430
Lelubre C, Anselin S, Zouaoui Boudjeltia K, Biston P, Piagnerelli M (2013) Interpretation of C-reactive protein concentrations in critically ill patients. Biomed Res Int 2013:124021
Lee KJ, Kim HM, Choi JS, Kim YJ, Kim YS, Cho JH (2016) Comparison of predictive systems in severe acute pancreatitis according to the revised Atlanta Classification. Pancreas. 45(1):46–50
Altaweel YA, Abdelaziz S, Fathy HA, AbdelBadea S (2018) Correlative study between C-reactive protein, clinical severity, and nerve conduction studies in Guillain-Barre syndrome. Egypt J Neurol Psychiatr Neurosurg 54(1):4
Ethemoglu O, Calik M (2018) Effect of serum inflammatory markers on the prognosis of adult and pediatric patients with Guillain-Barre syndrome. Neuropsychiatr Dis Treat 14:1255–1260
Tunc A (2019) Early predictors of functional disability in Guillain-Barre syndrome. Acta Neurol Belg 119(4):555–559
Li X, Li B, Zeng H, Wang S, Sun X, Yu Y, Wang L, Yu J (2019) Prognostic value of dynamic albumin-to-alkaline phosphatase ratio in limited stage small-cell lung cancer. Future Oncol 15(9):995–1006
Zhang D, Yan H, Wei Y, Liu X, Zhuang Z, Dai W, Li J, Li W, Hang C (2019) C-reactive protein/albumin ratio correlates with disease severity and predicts outcome in patients with aneurysmal subarachnoid hemorrhage. Front Neurol 10:1186
Moon JS, Ahn SS, Park YB, Lee SK, Lee SW (2018) C-reactive protein to serum albumin ratio is an independent predictor of all-cause mortality in patients with ANCA-associated vasculitis. Yonsei Med J 59(7):865–871
Ge X, Cao Y, Wang H, Ding C, Tian H, Zhang X, Gong J, Zhu W, Li N (2017) Diagnostic accuracy of the postoperative ratio of C-reactive protein to albumin for complications after colorectal surgery. World J Surg Oncol. 15(1):15
Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol 27(Suppl):S21–S24
Wu X, Li C, Zhang B, Shen D, Li T, Liu K, Zhang HL (2015) Predictors for mechanical ventilation and short-term prognosis in patients with Guillain-Barre syndrome. Crit Care 19:310
Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM (1978) Controlled trial prednisolone in acute polyneuropathy. Lancet. 2(8093):750–753
Teitelbaum JS, Borel CO (1994) Respiratory dysfunction in Guillain-Barre syndrome. Clin Chest Med 15(4):705–714
Wijdicks EF, Borel CO (1998) Respiratory management in acute neurologic illness. Neurology. 50(1):11–20
Szalai AJ (2004) C-reactive protein (CRP) and autoimmune disease: facts and conjectures. Clin Dev Immunol 11(3–4):221–226
Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature. 454(7203):436–444
Sun F, Ge X, Liu Z, Du S, Ai S, Guan W (2017) Postoperative C-reactive protein/albumin ratio as a novel predictor for short-term complications following gastrectomy of gastric cancer. World J Surg Oncol 15(1):191
Tao C, Wang J, Hu X, Ma J, Li H, You C (2017) Clinical value of neutrophil to lymphocyte and platelet to lymphocyte ratio after aneurysmal subarachnoid hemorrhage. Neurocrit Care 26(3):393–401
Acknowledgments
We thank the Guillain-Barré syndrome patients for their participation in our study.
Funding
This work was supported by the Basic Conditions Platform Construction Project of Sichuan Science and Technology Department (2019JDPT0015), the “1・3・5 project for disciplines of excellence, West China Hospital, Sichuan University” (ZYJC18003), and the Yunnan Applied Basic Research Project (2019FE001(-048)).
Author information
Authors and Affiliations
Contributions
Conceptualization: Pingping Ning, Baiyuan Yang, Xinglong Yang, Yanming Xu; Methodology: Pingping Ning, Baiyuan Yang, Xinglong Yang; Formal analysis and investigation: Hongyan Huang, Qiuyan Shen, Quanzhen Zhao, Haitao Lu, Li Yang, Sijia Tian; Writing—original draft preparation: Pingping Ning; Writing—review and editing: Baiyuan Yang, Yanming Xu; Supervision: Yanming Xu
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This study was approved by the Ethics Committee of West China Hospital, Sichuan University.
Consent to participate
Written informed consent was obtained from all patients for their anonymized clinical data to be published for research purposes.
Consent for publication
Written informed consent was obtained from all patients for their anonymized clinical data to be published for research purposes.
Code availability
The code used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Heading
1. A ratio of C-reactive protein-to-albumin > 0.21, a novel inflammatory biomarker, is independently associated with the occurrence of respiratory failure in GBS patients.
2. A ratio of C-reactive protein-to-albumin > 0.19 is independently associated with poor short-term outcome in GBS patients.
3. The ratio of C-reactive protein-to-albumin predicts prognosis better than C-reactive protein alone.
Rights and permissions
About this article
Cite this article
Ning, P., Yang, B., Yang, X. et al. Clinical value of C-reactive protein/albumin ratio in Guillain-Barré syndrome. Neurol Sci 42, 3275–3283 (2021). https://doi.org/10.1007/s10072-020-04930-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-020-04930-4